Virtus ETF Advisers’s MoonLake Immunotherapeutics MLTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-1,322
| Closed | -$71.6K | – | 507 |
|
|
2024
Q4 | $71.6K | Sell |
1,322
-840
| -39% | -$45.5K | 0.03% | 360 |
|
|
2024
Q3 | $109K | Buy |
2,162
+42
| +2% | +$2.12K | 0.05% | 363 |
|
|
2024
Q2 | $93.2K | Buy |
2,120
+616
| +41% | +$27.1K | 0.05% | 343 |
|
|
2024
Q1 | $75.5K | Sell |
1,504
-101
| -6% | -$5.07K | 0.04% | 399 |
|
|
2023
Q4 | $96.9K | Sell |
1,605
-2,082
| -56% | -$126K | 0.06% | 370 |
|
|
2023
Q3 | $210K | Sell |
3,687
-366
| -9% | -$20.9K | 0.13% | 243 |
|
|
2023
Q2 | $207K | Buy |
+4,053
| New | +$207K | 0.12% | 298 |
|